MedPath

PHEBRA (SE ASIA) PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

HSA:6

Drug Approvals

BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML

Approval Date
Jun 3, 2021
HSA

INDIGO CARMINE INJECTION 20 mg/5 ml

Approval Date
Aug 16, 2000
HSA

DEHYDRATED ALCOHOL INJECTION BP

Approval Date
Jun 11, 1991
HSA

ASCORBIC ACID INJECTION USP 500 mg/5 ml

Approval Date
May 21, 1991
HSA

HAEMOROL™, OILY PHENOL INJECTION 250MG/5ML

Approval Date
May 6, 1989
HSA

PARALDEHYDE INJECTION BP

Approval Date
Apr 22, 1988
HSA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.